THOMAS HAUGHEY
CIK 1272247 · President · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.34M
Companies
3
Total Filings
44
Lifetime Open-Market Net
-$7.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 40,878 | $81.68 | $3.34M | -$1.50M | 10 | 2026-06-10 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | Director | 6,291 | $14.49 | $91.2K | $173.2K | 3 | 2019-05-15 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | President | 70,548 | — | — | -$6.29M | 30 | 2012-01-13 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-01-17 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +36,849 | $0 | EDGAR |
| 2008-01-15 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +36,849 | $0 | EDGAR |
| 2007-10-03 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Buy (P) | +2,500 | $45.5K | EDGAR |
| 2007-03-26 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +28,200 | $0 | EDGAR |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.